INVO Fertility, Inc. (IVF) earnings date, results and what the price requires

    Nasdaq · SEC CIK 0001417926 · SEC filings checked Oct 17, 2026

    Next report
    Nov 19, 2026
    Estimated from reporting history (94-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
    Last close
    $0.59
    Polygon.io daily close, Oct 15, 2026. End of day, not live.
    Trailing diluted EPS
    $3620.49
    Sum of quarters ending Jun 30, 2026, Mar 31, 2026, Dec 31, 2025, Sep 30, 2025 · P/E 0.0

    Previous results (SEC filings)

    Quarter endedReportedRevenueNet incomeDiluted EPSSource
    Jun 30, 2026Aug 17, 2026$2.2M$888,740$0.35Filing
    Mar 31, 2026Jun 2, 2026$2.0M$-5.5M$-3.38Filing
    Dec 31, 2025Jun 2, 2026$1.6M$47.7M$3662.92Filing
    Sep 30, 2025Nov 17, 2025$1.8M$-3.4M$-39.40Filing
    Jun 30, 2025Aug 15, 2025$1.9M$-3.6M$-364.23Filing
    Mar 31, 2025Apr 30, 2025$1.6M$-17.4M$-3473.93Filing
    Dec 31, 2024Apr 30, 2025$1.7M$14.5M$-3737.60Filing
    Sep 30, 2024Nov 19, 2024$1.4M$-1.6M$-15.11Filing

    What would INVO Fertility, Inc. have to report for its valuation to change?

    At $0.59, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -89.3% a year, to $0.05. On that path the next quarter needs diluted EPS near $-4.21, against $-39.40 in the quarter ended Sep 30, 2025.

    Are you considering buying, or do you already own shares?

    Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.

    ResultOriginalYours
    Required EPS growth / year-89.3%-89.3%
    EPS needed in final year$0.05$0.05

    Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.

    Prepare for earnings across my investments — $399/month

    Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. IVF goes in with your buy-or-wait comparison and assumptions preserved.

    Start Desk — $399/month

    Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.